About Contact Us Careers

Tay-Sachs Disease Treatment Market Trends

Request Free Sample Copy

Report ID: 3092
Published Date: Sep 02, 2024
Report Format: PDF, PPT

Buy Now

Tay-Sachs Disease Treatment Market Trends

Growth Drivers

Growing Population of High-Risk Communities
High Investment in R&D Activities, to Develop Treatment Methods

Challenges

High Cost of Treatment
Circulation of Generic Drugs in the Market

Tay-Sachs Disease Treatment Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	5.7%
Base Year Market Size (2023)	USD 2.29 billion
Forecast Year Market Size (2036)	USD 4.71 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Tay-Sachs Disease Treatment Market Size & Share, Growth Trends 2036

Author Credits: Radhika Pawar

Report ID: 3092
Published Date: Sep 02, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of tay-sachs disease treatment is estimated at USD 2.39 billion.

Tay-Sachs Disease Treatment Market size was over USD 2.29 billion in 2023 and is anticipated to reach USD 4.71 billion by 2036, witnessing around 5.7% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of the genetic disease in specific communities, and growing R&D investment for medical research will impel the market growth.

North America is likely to hold largest revenue share by 2036, on the back of growing cases of Tay-Sachs disease in the region.

The major players in the market are Sio Gene Therapies Ltd, Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Amgen Inc. and others who manufacture drugs to treat the symptoms of Tay-Sachs disease.

Inquiry Before Buying Request Free Sample